120 related articles for article (PubMed ID: 22280018)
1. Coronary flow velocity reserve is improved by PPAR-α agonist fenofibrate in patients with hypertriglyceridemia.
Wang G; He L; Liu J; Yu J; Feng X; Li F; Hao Y; Mao J; Hong T; Chen AF; Wang X
Cardiovasc Ther; 2013 Jun; 31(3):161-7. PubMed ID: 22280018
[TBL] [Abstract][Full Text] [Related]
2. Peroxisome proliferator-activated receptor gamma agonist improves arterial stiffness in patients with type 2 diabetes mellitus and coronary artery disease.
Yu J; Jin N; Wang G; Zhang F; Mao J; Wang X
Metabolism; 2007 Oct; 56(10):1396-401. PubMed ID: 17884451
[TBL] [Abstract][Full Text] [Related]
3. PPAR-α Agonist Fenofibrate Decreased RANTES Levels in Type 2 Diabetes Patients with Hypertriglyceridemia.
Feng X; Gao X; Jia Y; Zhang H; Xu Y; Wang G
Med Sci Monit; 2016 Mar; 22():743-51. PubMed ID: 26944934
[TBL] [Abstract][Full Text] [Related]
4. Beneficial effects of fenofibrate to improve endothelial dysfunction and raise adiponectin levels in patients with primary hypertriglyceridemia.
Koh KK; Han SH; Quon MJ; Yeal Ahn J; Shin EK
Diabetes Care; 2005 Jun; 28(6):1419-24. PubMed ID: 15920062
[TBL] [Abstract][Full Text] [Related]
5. Fenofibrate, a peroxisome proliferator-activated receptor alpha, improves myocardial capillary density in diabetic rats.
Salehi E; Khazaei M
J Pak Med Assoc; 2012 Mar; 62(3 Suppl 2):S9-12. PubMed ID: 22768449
[TBL] [Abstract][Full Text] [Related]
6. Effects of fenofibrate on lipoproteins, vasomotor function, and serological markers of inflammation, plaque stabilization, and hemostasis.
Kon Koh K; Yeal Ahn J; Hwan Han S; Kyu Jin D; Sik Kim H; Cheon Lee K; Kyun Shin E; Sakuma I
Atherosclerosis; 2004 Jun; 174(2):379-83. PubMed ID: 15136070
[TBL] [Abstract][Full Text] [Related]
7. Homocysteine impairs coronary artery endothelial function by inhibiting tetrahydrobiopterin in patients with hyperhomocysteinemia.
He L; Zeng H; Li F; Feng J; Liu S; Liu J; Yu J; Mao J; Hong T; Chen AF; Wang X; Wang G
Am J Physiol Endocrinol Metab; 2010 Dec; 299(6):E1061-5. PubMed ID: 20858749
[TBL] [Abstract][Full Text] [Related]
8. Angiotensin receptor blocker improves coronary flow velocity reserve in hypertensive patients: comparison with calcium channel blocker.
Kamezaki F; Tasaki H; Yamashita K; Shibata K; Hirakawa N; Tsutsui M; Kouzuma R; Nagatomo T; Adachi T; Otsuji Y
Hypertens Res; 2007 Aug; 30(8):699-706. PubMed ID: 17917317
[TBL] [Abstract][Full Text] [Related]
9. Effect of fenofibrate on the level of asymmetric dimethylarginine in individuals with hypertriglyceridemia.
Yang TL; Chen MF; Xia X; Luo BL; Li YJ
Eur J Clin Pharmacol; 2006 Mar; 62(3):179-84. PubMed ID: 16447050
[TBL] [Abstract][Full Text] [Related]
10. Fenofibrate and pioglitazone improve endothelial function and reduce arterial stiffness in obese glucose tolerant men.
Ryan KE; McCance DR; Powell L; McMahon R; Trimble ER
Atherosclerosis; 2007 Oct; 194(2):e123-30. PubMed ID: 17145061
[TBL] [Abstract][Full Text] [Related]
11. Effect of fenofibrate on serum nitric oxide levels in patients with hypertriglyceridemia.
Esenboga K; Çiçek ÖF; Oktay AA; Ayral PA; Gürlek A
Adv Clin Exp Med; 2019 Jul; 28(7):931-936. PubMed ID: 31237119
[TBL] [Abstract][Full Text] [Related]
12. [Correlation of large artery stiffness and coronary flow velocity reserve].
Hao YT; Zhang YZ; Mao JM; He LY; Yu J; Wang C; Feng JL; Liu JB; Feng XH; Hong TP; Wang G
Zhonghua Yi Xue Za Zhi; 2012 Mar; 92(10):685-8. PubMed ID: 22781296
[TBL] [Abstract][Full Text] [Related]
13. Serum homocysteine increases after therapy with fenofibrate or bezafibrate.
Dierkes J; Westphal S; Luley C
Lancet; 1999 Jul; 354(9174):219-20. PubMed ID: 10421307
[TBL] [Abstract][Full Text] [Related]
14. Effect of micronized fenofibrate on vascular endothelial function in patients with hypertriglyceridemia.
Huang Y; Dai G; Feng Z; Lu C; Cheng B; Wang Q; Nie F; Li J
Chin Med J (Engl); 2003 Nov; 116(11):1767-9. PubMed ID: 14642156
[TBL] [Abstract][Full Text] [Related]
15. Effects of fenofibrate and gemfibrozil on plasma homocysteine.
Chan NN; Chow FC
Lancet; 2001 Nov; 358(9295):1811; author reply 1811-2. PubMed ID: 11734263
[No Abstract] [Full Text] [Related]
16. [Fibrates].
Yamada N
Nihon Rinsho; 2002 May; 60(5):962-7. PubMed ID: 12030000
[TBL] [Abstract][Full Text] [Related]
17. Fenofibrate reduces fasting and postprandial inflammatory responses among hypertriglyceridemia patients with the metabolic syndrome.
Rosenson RS; Huskin AL; Wolff DA; Helenowski IB; Rademaker AW
Atherosclerosis; 2008 Jun; 198(2):381-8. PubMed ID: 18242616
[TBL] [Abstract][Full Text] [Related]
18. [Effect of pulse wave velocity on coronary flow reserve in patients with essential hypertension].
Wang GH; Hu DY
Zhonghua Yi Xue Za Zhi; 2005 Jan; 85(1):54-7. PubMed ID: 15808080
[TBL] [Abstract][Full Text] [Related]
19. Long-term fenofibrate therapy increases fibroblast growth factor 21 and retinol-binding protein 4 in subjects with type 2 diabetes.
Ong KL; Rye KA; O'Connell R; Jenkins AJ; Brown C; Xu A; Sullivan DR; Barter PJ; Keech AC;
J Clin Endocrinol Metab; 2012 Dec; 97(12):4701-8. PubMed ID: 23144467
[TBL] [Abstract][Full Text] [Related]
20. Acute effect of oral vitamin C on coronary circulation in young healthy smokers.
Teramoto K; Daimon M; Hasegawa R; Toyoda T; Sekine T; Kawata T; Yoshida K; Komuro I
Am Heart J; 2004 Aug; 148(2):300-5. PubMed ID: 15309000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
